GLYTR THERAPEUTICS
GlyTR Therapeutics develops a novel immunotherapy platform technology targeting diverse cancer types, from breast cancer to leukemia. The company is based on research that has come out of UC Irvine’s Research Lab and founded by Dr. Michael Demetriou and Dr. Raymond Zhou.
GLYTR THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Diagnostics Medical Therapeutics
Founded:
2015-01-01
Address:
Irvine, California, United States
Country:
United States
Website Url:
http://www.glytrtherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Similar Organizations
Candel Therapeutics
Candel Therapeutics develops cancer immunotherapies designed to improve the lives of cancer patients and their families.
Pacylex
Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Advisors List
Current Employees Featured
Founder
Investors List
EvoNexus
EvoNexus investment in Non Equity Assistance - GlyTR Therapeutics
Official Site Inspections
http://www.glytrtherapeutics.com
- Host name: 9.0.153.160.host.secureserver.net
- IP address: 160.153.0.9
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "GlyTR Therapeutics"
Home - GlyTR Therapeutics
GlyTR is developing an entirely new class of antibody-independent immunotherapeutics. Today’s antibody-based immunotherapies are far from perfect. Limited There are a limited number of …See details»
GlyTR Therapeutics - Crunchbase Company Profile
Contact Email [email protected] GlyTR Therapeutics develops a novel immunotherapy platform technology targeting diverse cancer …See details»
GlyTR Therapeutics, Inc. - Orange County, California, United States ...
GlyTR is an innovative cancer immunotherapy platform technology that will change the paradigm for cancer treatment. · GlyTR Therapeutics Inc. was co-founded by Professor Michael …See details»
GlyTR Therapeutics - Craft
GlyTR Therapeutics is a biotech company developing immunotherapeutic anti-cancer molecules and cells. Its technology targets diverse cancer types, ranging from breast cancer to leukemia.See details»
GlyTR Therapeutics - PitchBook
GlyTR Therapeutics General Information Description. Operator of a biotech company intended to develop immunotherapeutic anti-cancer molecules and cells. The company develops …See details»
GlyTR Therapeutics, Inc. - Company Profile & Staff Directory
GlyTR Therapeutics (pronounced “glitter”) is an early stage biotech company based in Irvine, CA dedicated to the ambitious goal of curing cancer. GlyTR Therapeutics has developed a …See details»
Glytr Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Glytr Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
GlyTR Therapeutics - Products, Competitors, Financials, Employees ...
GlyTR Therapeutics is an early-stage biotech company focused on developing a new class of immunotherapeutic anti-cancer treatments. Use the CB Insights Platform to explore GlyTR …See details»
GlyTR Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for GlyTR Therapeutics, Inc. of Irvine, CA. Get the latest business insights from Dun & Bradstreet.See details»
GLYTR THERAPEUTICS INC Irvine CA, 92617 - Company Profile
Free Business profile for GLYTR THERAPEUTICS INC at 5151 California Ave, Irvine, CA, 92617-3206, US. GLYTR THERAPEUTICS INC specializes in: Pharmaceutical Preparations.See details»
Contact - GlyTR Therapeutics
[email protected]. Offices. 5151 California Ave Ste 150 Irvine CA 92617 US ...See details»
Glytr Therapeutics - Overview, News & Similar companies
Oct 22, 2018 Popular Searches GlyTR Therapeutics Inc GlyTR Therapeutics Glytrtherapeutics SIC Code 87,873 NAICS Code 54,541 Show more. Similar Companies to Glytr Therapeutics. …See details»
GlyTR Therapeutics, Inc. - Overview, Competitors, And ... - Ampliz
Website: www.glytrtherapeutics.com. Founded: 2016. Employees: 0-10 . Stock Exchange: NA . Immuno-Oncology Biotechnology . About GlyTR Therapeutics, Inc. GlyTR Therapeutics …See details»
GlyTR Therapeutics | CipherBio
Explore GlyTR Therapeutics's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
GlyTR Therapeutics ‘Cancer Moonshot’ Technology Receives …
Oct 22, 2018 For scientific information, contact: [email protected] and for investor information and/or the CEO opportunity, contact: [email protected].See details»
News - GlyTR Therapeutics
IRVINE, Calif.–(BUSINESS WIRE)–GlyTR Therapeutics, Inc. is pleased to announce it has been awarded an approximately $300,000 grant from The National Cancer Institute (NCI), National …See details»
GlyTR Therapeutics ‘Cancer Moonshot’ Technology Receives …
IRVINE, Calif.–(BUSINESS WIRE)–GlyTR Therapeutics, Inc. is pleased to announce it has been awarded an approximately $300,000 grant from The National Cancer Institute (NCI), National …See details»
Robert Genthert - Interim Chief Executive Officer - LinkedIn
Interim CEO at GlyTR Therapeutics, Inc. · As a board member I am focusing my efforts on hiring a world-class biomedical CEO and raising Series A to support GlyTR Therapeutics' …See details»
GlyTR Therapeutics – UCI Beall Applied Innovation
Sep 20, 2016 To learn more about GlyTR Therapeutics, please visit: glytrtherapeutics.com. You've Come This Far, Now Go All the Way. Search Our Technology Book Your Event Rent …See details»
U.S. FDA Grants Full Approval of VITRAKVI® (larotrectinib) for …
WHIPPANY, N.J., April 10, 2025 – Bayer today announced that the U.S. Food and Drug Administration (FDA) has granted full approval for VITRAKVI® (larotrectinib), a first-in-class …See details»